v3.19.3
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets    
Cash $ 144,971 $ 118,307
Accounts receivable - net 226,039 64,345
Inventory 3,079 3,079
Prepaid and other 46,393 46,596
Total current assets 420,482 232,327
Property and equipment, net of accumulated depreciation of $400,993 and $495,331, respectively 279,854 381,301
Land 603,000 603,000
Goodwill 3,749,963 2,092,048
Deposits 19,600 24,600
Right of use - assets 357,650 0
Other assets 30,494 7,790
Total assets 5,461,043 3,341,066
Current liabilities    
Accounts payable and accrued expense 710,708 1,094,521
Accrued expenses - related parties 1,137,000 747,000
Interest payable 513,213 366,297
Right of use - liability 357,650 0
Due to officers and shareholders 175,266 137,816
Deferred Income 153,226 1,036,039
Line of credit 0 1,999
Common stock to be issued 500 500
Notes payable, unrelated party 597,629 676,477
Notes payable - related party 296,916 265,242
Convertible notes payable, net of debt discounts of $269,866 and $201,024, respectively 648,866 950,776
Net, liabilities of discontinued operations 2,152,199 0
Derivative Liability 7,351,185 1,870,625
Total current liabilities 14,094,358 7,147,292
Other Liabilities    
Convertible notes payable, net of current portion and net of debt discounts of $465,828 and $0, respectively 374,172 1,040,000
Total liabilities 14,468,530 8,187,292
Deficiency in Stockholders' Equity    
Preferred I Shares to be issued 200,000
Common stock; 7,500,000,000 shares authorized with $0.001 par value;524,346,331 and 602,826 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively (reflects post reverse stock split of 1500:1) 524,347 603
Additional paid-in capital 54,654,595 50,220,067
Accumulated deficit (64,511,706) (55,378,603)
Total deficiency in stockholders' equity (9,007,487) (4,846,227)
Total liabilities and deficiency in stockholders' equity 5,461,043 3,341,065
Preferred Stock Series A [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes
Preferred Stock Series B [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes 2,773 2,773
Preferred Stock Series C [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes
Series D Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes 400 400
Series E Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes 241 241
Series F Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes 280 280
Series F-1 Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes 57 57
Series G Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes 18,571
Series H Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes
Series H-1 Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes
Series I Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes 195,000
Series J Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes
Series J1 Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes
Series K Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes 8,200 8,200
Series K1 Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes 1,447 1,447
Series L Preferred Stock [Member]    
Deficiency in Stockholders' Equity    
Preferred Stock all classes $ 98,308 $ 98,308

Source